Iga Swiatek expressed her fear of a hostile reaction to her recent doping ban, following a one-month suspension due to a positive test for the heart medication trimetazidine. The International Tennis Integrity Agency determined her test result was due to contamination from a non-prescription medication. While Swiatek does not anticipate an appeal from the World Anti-Doping Agency, she shared her relief over the positive public response to her situation, particularly in Poland, despite some negative comments. Swiatek missed key tournaments during her suspension but remains grateful for the support received.